Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:57:22.397Z.
Calculation as of: 2026-10-06T14:57:22.397Z.
Quote observation: 2026-10-06T14:55:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3ba604bfa669edc564cc368ab96d70220aa63ab01e3d3e65254ff63c7dd77471
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Immuneering Corporation
Market Cap
$144.48M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$144.00M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.15M
Operating Cash Flow Yield
0.90%
TTM Avg
3.24%
3Y Avg
4.92%
5Y Avg
5.15%
Market Cap
$147.13M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$147.97M
Operating Cash Flow Yield
N/A
TTM Avg
1.16%
3Y Avg
1.36%
5Y Avg
1.36%
Market Cap
$139.73M
Operating Cash Flow Yield
90.12%
TTM Avg
20.54%
3Y Avg
20.54%
5Y Avg
20.54%
Market Cap
$139.63M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$150.23M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $144.48M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.00M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $142.60M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $142.15M | 0.90% | 3.24% | 4.92% | 5.15% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.13M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | N/A | 1.16% | 1.36% | 1.36% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 90.12% | 20.54% | 20.54% | 20.54% |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.23M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
